Related Experiment Video
Updated: Sep 20, 2026
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Construction of antisense transforming growth factor beta 1 gene and its effect on the proliferation by expression in
Yong Liu1, Qixin Zheng, Jingyuan Du
1Department of Orthopaedics, Xiehe Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022.
Abstract:
To construct the antisense transforming growth factor beta 1 (TGF beta 1) gene and investigate the effect of TGF beta 1 autocrine loop blockage on the proliferation of osteosarcoma cells. TGF beta 1 cDNA was cloned by RT-PCR from human osteosarcoma cells (MG-63) and inserted into pcDNA3 to construct an antisense expression vector, which was dubbed pcDNA3-TGF beta 1(-). MTT was used to detect the proliferation of osteosarcoma cells transfected by antisense TGF beta 1 gene. Our results showed that the proliferation of the transfected osteosarcoma cells was suppressed markedly. It is concluded that TGF beta 1 autocrine loop blockage in osteosarcoma cells could inhibit cell proliferation, which might be helpful for gene therapy of osteosarcoma.
Insights
Blocking the transforming growth factor beta 1 (TGF beta 1) autocrine loop in osteosarcoma cells significantly suppressed their proliferation. This finding suggests potential for TGF beta 1 gene therapy in osteosarcoma treatment.
Area of Science:
- Molecular Biology
- Oncology
- Gene Therapy
Background:
- The transforming growth factor beta 1 (TGF beta 1) signaling pathway plays a crucial role in cell growth and differentiation.
- Aberrant TGF beta 1 signaling is implicated in the development and progression of various cancers, including osteosarcoma.
- Understanding the TGF beta 1 autocrine loop in osteosarcoma is essential for developing targeted therapeutic strategies.
Purpose of the Study:
- To construct an antisense gene targeting transforming growth factor beta 1 (TGF beta 1).
- To investigate the impact of blocking the TGF beta 1 autocrine loop on osteosarcoma cell proliferation.
- To evaluate the potential of this approach for osteosarcoma gene therapy.
Main Methods:
- Cloning of TGF beta 1 cDNA from human osteosarcoma cells (MG-63) using RT-PCR.
- Construction of an antisense expression vector (pcDNA3-TGF beta 1(-)).
- Assessment of osteosarcoma cell proliferation using the MTT assay following transfection with the antisense TGF beta 1 gene.
Main Results:
- Successful construction of the antisense TGF beta 1 expression vector.
- Significant suppression of proliferation in osteosarcoma cells transfected with the antisense TGF beta 1 gene.
- Demonstration of TGF beta 1's role in promoting osteosarcoma cell growth.
Conclusions:
- Blockage of the TGF beta 1 autocrine loop effectively inhibits osteosarcoma cell proliferation.
- Antisense TGF beta 1 gene therapy holds promise for the treatment of osteosarcoma.
- Targeting the TGF beta 1 pathway represents a viable strategy for inhibiting osteosarcoma growth.
